EUVIMEDEUVIMED entdecken
Crossref

Is there a role of miRNA -330-3p and miRNA-362-3p in Lupus Nephritis?

Mohamed F A Assar, Eman A Badr, Safwa O Toulan, Ashwak N I Elhalafawy, Basma A Mostafa

The Egyptian journal of Immunology · 2025

DOI: 10.55133/eji.320405 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Egyptian journal of Immunology, 2025. Verfasst von Mohamed F A Assar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Biochemistry Division, Faculty of Science, Menoufia University, Menoufia, Egypt. Hauptthemen laut MEDLINE: Lupus Nephritis, MicroRNAs, Lupus Erythematosus, Systemic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic lupus erythematosus (SLE) is an autoimmune disease, with lupus nephritis (LN) being one of its most serious complications. MicroRNAs, particularly miRNA-330-3p and miRNA-362-3p, were implicated in immune regulation and inflammation. This study aimed to evaluate the potential role of miRNA-330-3p and miRNA-362-3p in the progression of SLE and LN. This cross-sectional study included 150 participants: 50 controls (Group I), 50 SLE patients without nephritis (Group II), and 50 patients with lupus nephritis (Group III). Serum levels of miRNA-330-3p and miRNA-362-3p were quantified using a real-time polymerase chain reaction (PCR) test. Clinical and laboratory parameters were assessed, including disease activity and nephritis classification. miRNA-330-3p levels were significantly lower in both patients without nephritis (1.119 ± 1.289) and patients with nephritis (0.89 ± 0.518) compared to controls (1.312 ± 0.480; p < 0.001). miRNA-362-3p levels were significantly lower in patients with nephritis (0.623 ± 0.925) than in both controls (1.268 ± 0.419; p < 0.001) and patients without nephritis (1.254 ± 1.351; p < 0.001). The receiver operating characteristic (ROC) curve analysis revealed that miRNA-362-3p discriminated LN from non-LN SLE patients (AUC = 0.754; cut off ≤ 0.204; sensitivity 66%, specificity 72%). Both miRNA-330-3p and miRNA-362-3p are down regulated in SLE, particularly in patients with LN. These miRNAs may represent therapeutic targets, pending validation in future studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus NephritisMicroRNAsLupus Erythematosus, SystemicHumansFemaleMaleAdultCross-Sectional StudiesMiddle AgedYoung AdultBiomarkersROC CurveDisease Progression

Substanzen

MicroRNAsBiomarkers

Autor:innen und Institutionen

  • Department of Chemistry, Biochemistry Division, Faculty of Science, Menoufia University, Menoufia, Egypt.
  • Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Menoufia University, Menoufia, Egypt.
  • Department of Internal Medicine, Nephrology Unit, Faculty of Medicine, Menoufia University, Menoufia, Egypt.

Zitieren

APA

Assar, M. F. A., Badr, E. A., Toulan, S. O., Elhalafawy, A. N. I., & Mostafa, B. A. (2025). Is there a role of miRNA -330-3p and miRNA-362-3p in Lupus Nephritis?. The Egyptian journal of Immunology. https://doi.org/10.55133/eji.320405

Vancouver

Assar MFA, Badr EA, Toulan SO, Elhalafawy ANI, Mostafa BA. Is there a role of miRNA -330-3p and miRNA-362-3p in Lupus Nephritis?. The Egyptian journal of Immunology. 2025. doi:10.55133/eji.320405

BibTeX
@article{Assar2025,
  author = {Assar, Mohamed F A and Badr, Eman A and Toulan, Safwa O and Elhalafawy, Ashwak N I and Mostafa, Basma A},
  title = {Is there a role of miRNA -330-3p and miRNA-362-3p in Lupus Nephritis?},
  journal = {The Egyptian journal of Immunology},
  year = {2025},
  doi = {10.55133/eji.320405}
}
Kostenlos starten →